Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from China Wah Yan Healthcare ( (HK:0648) ).
SoftMedx Healthcare Limited reported its audited consolidated final results for the year ending December 31, 2024. The company achieved a significant profit before income tax of HK$327,954,000, a substantial increase from HK$14,369,000 in 2023, primarily due to a gain on debt restructuring. Despite a decrease in gross profit from HK$21,125,000 in 2023 to HK$18,398,000 in 2024, the company’s financial position improved markedly, with net assets of HK$2,456,000 compared to a net liability position of HK$323,861,000 the previous year. This financial turnaround indicates a positive impact on the company’s operations and potential strengthening of its market position.
More about China Wah Yan Healthcare
Current Market Cap: HK$123.9M
See more data about 0648 stock on TipRanks’ Stock Analysis page.